Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria

Archives of Virology

Volumn 156, Issue 9, 2011, Pages 1603-1606

  Charpentier, Charlotte ^a   Gody, Jean Chrysostome ^b   Tisserand, Pascaline ^a   Matta, Mathieu ^a   Fournier, Julien ^a   Mbitikon, Olivia ^b   Bélec, Laurent ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b Hôpital de l'Amitié   (Central African Republic)

Author keywords

Antiretroviral drug resistance; Central African Republic; Children; Dried blood spot; HIV 1 non B subtypes

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ANTIVIRAL RESISTANCE; ARTICLE; BLOOD; BLOOD SAMPLING; CENTRAL AFRICAN REPUBLIC; CHILD; DRUG EFFECT; GENETICS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; TREATMENT FAILURE; VIROLOGY;

ANTI-HIV AGENTS; BLOOD SPECIMEN COLLECTION; CENTRAL AFRICAN REPUBLIC; CHILD; DRUG RESISTANCE, VIRAL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; RNA, VIRAL; TREATMENT FAILURE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80052260338     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-011-0997-9     Document Type: Article

References (16)

1. Sendagire H, Easterbrook PJ, Nankya I, Arts E, Thomas D, Reynolds SJ (2009) The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART. AIDS Rev 11: 59-70.
2. Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke de Wit TF, Schuurman R, PharmAccess African Studies to Evaluate Resistance Programme (2008) The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa. Antivir Ther 13: 625-639.
3. World Health Organization (WHO) recommendations (2010) Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach 2010 revision. http://whqlibdoc. who. int/publications/2010/9789241599764_eng. pdf. Accessed 3 Jan 2011.
4. Charpentier C, Talla F, Nguepi E, Si-Mohamed A, Bélec L (2010) Virological failure and HIV-1 drug resistance profiles among patients followed-up in private sector, Douala, Cameroon. AIDS Res Hum Retroviruses 2011(27): 221-230.
5. Gody JC, Charpentier C, Mbitikon O, Si-Mohamed A, LeGoff J, Grésenguet G, Bélec L (2008) High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations. J Acquir Immune Defic Syndr 49: 566-569.
6. Hamers RL, Smit PW, Stevens R, Schuurman R, Rinke de Wit TF (2009) Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. Antivir Ther 14: 619-629.
7. Behets F, Kashamuka M, Pappaioanou M, Green TA, Ryder RW, Batter V, George JR, Hannon WH, Quinn TC (1992) Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire. J Clin Microbiol 30: 1179-1182.
8. Kane CT, Ndiaye HD, Diallo S, Ndiaye I, Wade AS, Diaw PA, Gaye-Diallo A, Mboup S (2008) Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal. J Virol Methods 148: 291-295.
9. Monleau M, Montavon C, Laurent C, Segondy M, Montes B, Delaporte E, Boillot F, Peeters M (2009) Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing. Clin Microbiol 47: 1107-1118.
10. Pasquier C, Millot N, Njouom R, Sandres K, Cazabat M, Puel J, Izopet J (2001) HIV-1 subtyping using phylogenetic analysis of pol gene sequences. J Virol Methods 94: 45-54.
11. Descamps D, Chaix ML, Montes B, Pakianather S, Charpentier C, Storto A, Barin F, Dos Santos G, Krivine A, Delaugerre C, Izopet J, Marcelin AG, Maillard A, Morand-Joubert L, Pallier C, Plantier JC, Tamalet C, Cottalorda J, Desbois D, Calvez V, Brun-Vezinet F, Masquelier B, Costagliola D, ANRS AC11 Resistance Study Group (2010) Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France. J Antimicrob Chemother 65: 2620-2627.
12. Youngpairoj AS, Masciotra S, Garrido C et al (2008) HIV-1 drug resistance genotyping from dried blood spots stored for 1 year at 4 degrees C. J Antimicrob Chemother 61: 1217-1220.
13. Garrido C, Zahonero N, Fernándes D, Serrano D, Silva AR, Ferraria N, Antúnes F, González-Lahoz J, Soriano V, de Mendoza C (2008) Subtype variability, virological response and drug resistance assessed on dried blood spots collected from HIV patients on antiretroviral therapy in Angola. J Antimicrob Chemother 61: 694-698.
14. Steegen K, Luchters S, Demecheleer E, Dauwe K, Mandaliya K, Jaoko W, Plum J, Temmerman M, Verhofstede C (2007) Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots. J Clin Microbiol 45: 3342-3351.
15. Hallack R, Doherty LE, Wethers JA, Parker MM (2008) Evaluation of dried blood spot specimens for HIV-1 drug-resistance testing using the Trugene HIV-1 genotyping assay. J Clin Virol 41: 283-287.
16. Masciotra S, Garrido C, Youngpairoj AS, McNulty A, Zahonero N, Corral A, Heneine W, de Mendoza C, García-Lerma JG (2007) High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients. AIDS 21: 2503-2511.